A Multicenter Study to Evaluate the Safety and Tolerability of Single-Dose for MEDI-545
NCT00472758
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Plaque Psoriasis
Interventions
BIOLOGICAL:
MEDI 545
OTHER:
Placebo
Sponsor
MedImmune LLC